Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 7617954, 7 pages
http://dx.doi.org/10.1155/2016/7617954
Research Article

Extra-Articular Symptoms in Constellation with Selected Serum Cytokines and Disease Activity in Spondyloarthritis

1Department of Rheumatology, Internal Medicine and Geriatrics, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland
2Independent Laboratory of Rheumatic Diagnostics, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland

Received 30 September 2016; Accepted 17 November 2016

Academic Editor: Yu Sun

Copyright © 2016 Hanna Przepiera-Będzak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Van Der Linden, H. A. Valkenburg, and A. Cats, “Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria,” Arthritis and Rheumatism, vol. 27, no. 4, pp. 361–368, 1984. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, and H. Mielants, “Classification criteria for psoriatic arthritis: development of new criteria from a large international study,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2665–2673, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. F. Kahn and M. A. Khan, “The SAPHO-syndrome,” in Psoriatic Arthritis. Bailliére's Clinical Rheumatology, H. Wright, Ed., vol. 8, pp. 333–362, 1994. View at Google Scholar
  4. I. Essers, S. Ramiro, C. Stolwijk et al., “Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS,” Rheumatology, vol. 54, no. 4, pp. 633–640, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Exarchou, U. Lindström, J. Askling et al., “The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study,” Arthritis Research & Therapy, vol. 17, no. 1, article 118, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. T. C. Mitulescu, C. Popescu, A. Naie et al., “Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis,” Journal of Medicine and Life, vol. 8, no. 3, pp. 319–325, 2015. View at Google Scholar
  7. R. Peluso, S. Iervolino, M. Vitiello, V. Bruner, G. Lupoli, and M. N. D. Di Minno, “Extra-articular manifestations in psoriatic arthritis patients,” Clinical Rheumatology, vol. 34, no. 4, pp. 745–753, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Stolwijk, A. van Tubergen, J. D. Castillo-Ortiz, and A. Boonen, “Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis,” Annals of the Rheumatic Diseases, vol. 74, no. 1, pp. 65–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Zarco, C. M. González, A. Rodríguez de la Serna et al., “Extra-articular disease in patients with spondyloarthritis. Baseline characteristics of the spondyloarthritis cohort of the AQUILES study,” Reumatologia Clinica, vol. 11, no. 2, pp. 83–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Gratacos, A. Collado, X. Filella et al., “Serum cytokines (IL-6, TNF-α, IL-β and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity,” British Journal of Rheumatology, vol. 33, no. 10, pp. 927–931, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Wendling, J.-P. Cedoz, and E. Racadot, “Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients,” Clinical Rheumatology, vol. 28, no. 2, pp. 187–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Hurtado-Nedelec, S. Chollet-Martin, P. Nicaise-Roland et al., “Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome,” Rheumatology, vol. 47, no. 8, pp. 1160–1167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Przepiera-Będzak, K. Fischer, and M. Brzosko, “Serum Interleukin-18, Fetuin-A, soluble intercellular adhesion molecule-1, and endothelin-1 in ankylosing spondylitis, psoriatic arthritis, and SAPHO syndrome,” International Journal of Molecular Sciences, vol. 17, no. 8, article 1255, 2016. View at Publisher · View at Google Scholar
  14. H. Przepiera-Będzak, K. Fischer, and M. Brzosko, “Serum IL-6 and IL-23 levels and their correlation with angiogenic cytokines and disease activity in ankylosing spondylitis, psoriatic arthritis, and SAPHO Syndrome,” Mediators of Inflammation, vol. 2015, Article ID 785705, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Drouart, P. Saas, M. Billot et al., “High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies,” Clinical & Experimental Immunology, vol. 132, no. 1, pp. 158–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Przepiera-Będzak, K. Fischer, and M. Brzosko, “Serum levels of angiogenic cytokines in psoriatic arthritis and SAPHO syndrome,” Polskie Archiwum Medycyny Wewnetrznej, vol. 123, no. 6, pp. 297–302, 2013. View at Google Scholar · View at Scopus
  17. H. Przepiera-Będzak, K. Fischer, and M. Brzosko, “Serum VEGF, EGF, basic FGF, and acidic FGF levels and their association with disease activity and extra-articular symptoms in ankylosing spondylitis,” Polish Archives of Internal Medicine, vol. 126, no. 4, pp. 290–292, 2016. View at Publisher · View at Google Scholar
  18. D. Wakefield, W. Yates, S. Amjadi, and P. McCluskey, “HLA-B27 anterior uveitis: immunology and immunopathology,” Ocular Immunology and Inflammation, vol. 24, no. 4, pp. 450–459, 2016. View at Publisher · View at Google Scholar
  19. R. Ghazizadeh, H. Shimizu, M. Tosa, and M. Ghazizadeh, “Pathogenic mechanisms shared between psoriasis and cardiovascular disease,” International Journal of Medical Sciences, vol. 7, no. 5, pp. 284–289, 2010. View at Google Scholar · View at Scopus
  20. D. Cibor, R. Domagala-Rodacka, T. Rodacki, A. Jurczyszyn, T. Mach, and D. Owczarek, “Endothelial dysfunction in inflammatory bowel diseases: pathogenesis, assessment and implications,” World Journal of Gastroenterology, vol. 22, pp. 1067–1077, 2016. View at Publisher · View at Google Scholar
  21. D. M. Ashcroft, A. Li Wan Po, H. C. Williams, and C. E. M. Griffiths, “Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality,” British Journal of Dermatology, vol. 141, no. 2, pp. 185–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Garrett, T. Jenkinson, L. G. Kennedy, H. Whitelock, P. Gaisford, and A. Calin, “A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index,” Journal of Rheumatology, vol. 21, no. 12, pp. 2286–2291, 1994. View at Google Scholar · View at Scopus
  23. M. Kramer, Y. Monselise, I. Bahar, Y. Cohen, D. Weinberger, and N. Goldenberg-Cohen, “Serum cytokine levels in active uveitis and remission,” Current Eye Research, vol. 32, no. 7-8, pp. 669–675, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kuryliszyn-Moskal, P. A. Klimiuk, S. Sierakowski, and M. Ciolkiewicz, “A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis,” Clinical Rheumatology, vol. 25, no. 3, pp. 314–319, 2006. View at Publisher · View at Google Scholar · View at Scopus